For Financial Professionals in the US
We believe in the sharing of expert insight for better investment and business decisions. We call this ethos Knowledge Shared.
Global Perspectives: ESG Is More than a Score
A discussion on why ESG analysis is more than just a "score" and how sustainable investing truly impacts the risk and return of all investors’ portfolios.
Subscribe for relevant insights delivered straight to your inbox
Why the push for government-negotiated drug prices could prove to be a Sisyphean task.
The highly infectious variant of COVID-19 has led to rising case numbers, but we explain why a return to normalcy is still within striking distance.
The sector is experiencing its worst period of relative underperformance on record. But some of history’s biggest biotech pains have been followed by memorable gains.
Underperforming the broad market for the first half of 2021, health care now offers attractive valuations and significant growth potential, thanks to innovation.
The Supreme Court’s decision to uphold the legislation may finally bring an end to challenges to the law and further expand health care in the U.S.
A new drug targeting a common mutation found in tumors represents a breakthrough in cancer therapy and a potential new source of growth for biopharma.
Why U.S. support for waiving intellectual property protections for COVID-19 vaccines does not spell the end of biotech growth.
In places where vaccination rates are rising, COVID-19 cases are dropping dramatically. What that means for ending the pandemic and health care long term.
How pharmaceutical companies are addressing the issue of inequitable access to medicine.
Making sense of the latest developments around COVID-19 variants and what investors should consider now.
Portfolio Manager Andy Acker says the health care sector looks set to ride a number of positive trends into 2021.
Delivering better-than-expected trial data, a vaccine candidate from Pfizer and BioNTech could mark the beginning of the end of the pandemic and boost confidence in an economic recovery, now underway.